Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 12:53:01 +0200Mon, 24 Jun 2024 15:52:00 +0200Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 16, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xaluprine-previously-mercaptopurine-nova-laboratoriesHuman medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 16, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xaluprine-previously-mercaptopurine-nova-laboratoriesMon, 24 Jun 2024 15:52:00 +0200Human medicineXaluprine : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2022-steps-after_en.pdfXaluprine : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2022-steps-after_en.pdfMon, 24 Jun 2024 02:00:00 +0200Human medicine